Not yet recruiting NCT06927089
Non-Invasive Hemodynamic Monitoring of MV ILD Patients With ARF
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Interstitial Lung Disease (ILD). Basic parameters: 18 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Non-Invasive Hemodynamic Monitoring of Interstitial Lung Disease Patients With Acute Respiratory Failure in Different Modes of Mechanical Ventilation
Overview
Non-invasive hemodynamic monitoring of interstitial lung disease (ILD) patients admitted to respiratory ICU with acute respiratory failure and differentiate according to different modes of mechanical ventilation.
Primary outcome measures
- Non-invasive Hemodynamic Monitoring [Time frame: 1 hour]
Eligibility criteria
Inclusion criteria
- Interstitial lung disease patients with acute respiratory failure admitted to respiratory ICU in different modes of MV (NIV, invasive MV and HVNI).
Exclusion criteria
\-
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Egypt · 1 center
- Assiut University — Asyut
Identifiers
NCT: NCT06927089 · CBBAAS